Case Series
The authors share early clinical experiences with once-daily edoxaban and discuss its evidence-based use in patients with non-valvular atrial fibrillation in Southeast Asia through several cases of patients at high risk
Review
The author present a narrative review that comprehensively addresses the pathophysiology, clinical manifestations, and therapeutic management of tachycardia-induced cardiomyopathy.
Case Report
This report describes the case of a 72-year-old man where anticoagulation therapy was postponed due to a haemorrhagic lesion, leading to new ischaemic stroke.
Review
This article discusses an update to the ANIBAL protocol in light of the COVID-19 pandemic.
Original Research
In this review, the available information on the antithrombotic management of atrial fibrillation patients at discharge after COVID-19 infection is updated. In addition, a practical algorithm, considering renal and liver function, which facilitates the anticoagulation choice at discharge is presented.
